Sign In
Buy MIRM
$91.84
-0.335 (-0.363%)
At Close: Jun 03, 2026
Mirum Pharmaceuticals (MIRM) in Focus: Stock Moves 5.9% Higher
09:47am, Tuesday, 22'nd Dec 2020
Mirum Pharmaceuticals (MIRM) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Mirum Pharmaceuticals Announces Pricing of Public Offering of Common Stock
09:00pm, Monday, 14'th Dec 2020
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapi
Mirum Pharmaceuticals Announces Commencement of Public Offering of Common Stock
07:00am, Monday, 14'th Dec 2020
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapi
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:41pm, Thursday, 10'th Dec 2020
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #AASLD--Mirum Data Presented at AASLD Highlighting Durable Improvements in Pruritus and Quality of Life in Children with ALGS Treated with Maralixibat
Mirum: Upcoming Catalyst In Rare Liver Disease, Strong Pipeline And Data
05:15am, Wednesday, 28'th Oct 2020
MoA reduces bile acid systemic levels. Potential utility across wide range of rare liver diseases.
Aligos Therapeutics Proposes Terms For $150 Million IPO (Pending:ALGS)
05:59pm, Monday, 12'th Oct 2020
Aligos Therapeutics has filed terms to raise $150 million in an IPO. The firm is developing treatments for chronic Hepatitis B and other liver and viral diseases.
Mirum Pharmaceuticals (MIRM) Presents At Digital International Liver Congress 2020
09:21am, Wednesday, 02'nd Sep 2020
The following slide deck was published by Mirum Pharmaceuticals, Inc. in conjunction with this event..
Mirum Pharmaceuticals (MIRM) Investor Presentation - Slideshow
05:54pm, Thursday, 27'th Aug 2020
The following slide deck was published by Mirum Pharmaceuticals, Inc. in conjunction with this event..
Stocks To Watch: Spotlight On Palo Alto Networks, Best Buy And Xpeng Motors
08:12am, Saturday, 22'nd Aug 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Stocks To Watch: Walmart, Target, Kandi And Gold vs. Bitcoin
08:30am, Saturday, 15'th Aug 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09:30pm, Tuesday, 11'th Aug 2020
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
We're Hopeful That Mirum Pharmaceuticals (NASDAQ:MIRM) Will Use Its Cash Wisely
01:42pm, Tuesday, 11'th Aug 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Companies Like Mirum Pharmaceuticals (NASDAQ:MIRM) Are In A Position To Invest In Growth
01:37pm, Tuesday, 11'th Aug 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12:00am, Tuesday, 11'th Aug 2020
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
